FILE - This undated image provided by Amgen Inc. shows the cholesterol-lowering drug Repatha. Contrary to some political claims, the FDA actually approved more drugs, including Repatha, and three months faster on average, than European regulators did over the last five years. Three researchers reviewed approvals in the U.S. and Europe and published their results Wednesday, April 5, 2017, in the New England Journal of Medicine. (Robert Dawson/Amgen via AP, File)
Featured Photo Galleries
